Dec 8, 2025 10:30AM
Nov 13, 2025 10:51AM
Nov 13, 2025 10:51AM
Sep 29, 2025 04:01PM
Sep 29, 2025 04:01PM
Sep 8, 2025 08:04PM
Sep 8, 2025 08:04PM AMGEN AND KYOWA KIRIN ANNOUNCE TOP-LINE RESULTS FROM ROCATINLIMAB PHASE 3 ASCEND LONG-TERM EXTENSION STUDY IN ADULTS WITH MODERATE TO SEVERE ATOPIC DERMATITIS
Jul 29, 2025 08:00AM
Jun 12, 2025 07:31AM
Jun 12, 2025 07:30AM
Jun 1, 2025 07:14PM
Jun 1, 2025 07:00PM
May 22, 2025 05:36PM
May 22, 2025 05:30PM Kura Oncology and Kyowa Kirin Announce Pivotal Monotherapy Data for Ziftomenib in Oral Presentation at the 2025 ASCO Annual Meeting
May 14, 2025 10:00AM
Apr 8, 2025 07:30AM
Apr 8, 2025 07:30AM
Mar 8, 2025 06:00AM
Feb 26, 2025 08:00AM
Feb 5, 2025 04:01PM
Dec 9, 2024 07:05AM Kura Oncology (KURA) and Kyowa Kirin Report Positive Combination Data for Ziftomenib at American Society of Hematology Annual Meeting
Dec 9, 2024 07:00AM
Nov 20, 2024 05:00PM
Oct 8, 2024 03:05AM
Sep 25, 2024 07:00AM
Sep 19, 2024 08:00AM
Aug 23, 2024 11:05AM
Apr 15, 2024 08:00AM First Interim Analysis of PROSPER Study Details Patient-Reported Symptom Burden of Mycosis Fungoides and Sézary Syndrome
Apr 12, 2024 09:00AM
Feb 7, 2024 07:34AM
Dec 11, 2023 08:30AM
Oct 16, 2023 10:04AM
Oct 12, 2023 09:00AM
Oct 5, 2023 03:35AM
Sep 25, 2023 06:56AM Ardelyx (ARDX) Announces Tenapanor for Hyperphosphatemia Approved in Japan
Sep 25, 2023 04:15AM
May 12, 2023 10:15AM
Apr 27, 2023 09:06AM
Dec 5, 2022 05:03PM
Dec 5, 2022 05:00PM
Nov 3, 2022 09:00AM
Oct 31, 2022 08:00AM Ardelyx Collaboration Partner, Kyowa Kirin, Announces Submission of New Drug Application for Tenapanor for Hyperphosphatemia in Japan
Sep 29, 2022 08:35AM
Jul 18, 2022 08:00AM
Jun 24, 2022 09:38AM
Jun 10, 2022 03:00AM
Jun 8, 2022 10:00AM
Jun 4, 2022 04:00PM
May 26, 2022 05:00PM MEI Pharma and Kyowa Kirin Announce Acceptance of Abstract for Presentation at the American Society of Clinical Oncology Annual Meeting 2022
May 12, 2022 10:00AM

312,667 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All